A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)

NCT01020955 ·Status: COMPLETED ·Phase: PHASE3

A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency

NCT02311894 ·Status: COMPLETED ·Phase: PHASE4

National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients

NCT00097513 ·Status: COMPLETED

National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

NCT00097539 ·Status: COMPLETED

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

NCT01109017 ·Status: COMPLETED

Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers

NCT01512095 ·Status: WITHDRAWN ·Phase: PHASE1

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

NCT02382939 ·Status: COMPLETED ·Phase: PHASE3

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

NCT01562834 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

NCT00376064 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

NCT01009905 ·Status: COMPLETED

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

NCT01502124 ·Status: COMPLETED ·Phase: PHASE3

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

NCT00102817 ·Status: COMPLETED ·Phase: PHASE3

Acute Application of Pegvisomant and Octreotide in Acromegaly

NCT00595140 ·Status: COMPLETED ·Phase: PHASE4

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

NCT05775523 ·Status: RECRUITING

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

NCT01580605 ·Status: COMPLETED

Open Label Study of Octreotide Implant in Patients With Acromegaly

NCT00913055 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

NCT01500486 ·Status: COMPLETED

Observational Study of Somatropin Treatment in Children

NCT01088412 ·Status: COMPLETED

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

NCT00490191 ·Status: COMPLETED ·Phase: PHASE4

A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults

NCT01088399 ·Status: COMPLETED

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

NCT03075644 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

NCT01673646 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

NCT02693522 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device

NCT01243892 ·Status: TERMINATED